in a prospective , randomized trial of 195 febrile episodes in granulocytopenic patients short course aminoglycoside treatment ( initial tobramycin and cefoperazone followed by tobramycin discontinuation at day four of therapy ) was compared with two regimens ( tobramycin plus cefoperazone and tobramycin plus mezlocillin ) in which both drugs were continued for up to 26 days .
C0002556
aminoglycoside
C0040341
tobramycin